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Single-cell mRNA-sequencing (scRNA-seq) is a technique which enables unbiased,
high throughput and high-resolution transcriptomic analysis of the heterogeneity of cells
within a population. This recent technique has been described in humans, mice and
other species in various conditions to cluster cells in populations and identify new
subpopulations, as well as to study the gene expression of cells in various tissues,
conditions and origins. In dogs, a species for which markers of cell populations are
often limiting, scRNA-seq presents with elevated yet untested potential for the study
of tissue composition. As a proof of principle, we used scRNA-seq to identify cellular
populations of the bronchoalveolar lavage fluid (BALF) in healthy dogs (n = 4). A total
of 5,710 cells were obtained and analyzed by scRNA-seq. Fourteen distinct clusters of
cells were identified, further identified as macrophages/monocytes (4 clusters), T cells (2
clusters) and B cells (1 cluster), neutrophils (1 cluster), mast cells (1 cluster), mature or
immature dendritic cells (1 cluster each), ciliated or non-ciliated epithelial cells (1 cluster
each) and cycling cells (1 cluster). We used for the first time in dogs the scRNA-seq to
investigate cellular subpopulations of the BALF of dog. This study hence expands our
knowledge on dog lung immune cell populations, paves the way for the investigation at
single-cell level of lower respiratory diseases in dogs, and establishes that scRNA-seq is
a powerful tool for the study of dog tissue composition.
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INTRODUCTION
The cells can be considered as the fundamental unit in biology. They are working in concert
to respond to stimuli in order to maintain health. However, until recently, they were only
characterized and distinguished using microscopy-based methods, flow cytometry, or bulk RNA
sequencing, all techniques that are quite limiting for demonstration of cell heterogeneity (1–4).
With the development of next-generation sequencing technologies, it is now possible to profile
the transcriptome of each individual cell composing a sample. The single-cell mRNA sequencing
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(scRNA-seq) enables high throughput and high-resolution
transcriptomic analysis of the cellular heterogeneity with an
unbiased assessment of the cells as it gives the opportunity to
identify cells without relying on previously known cell markers.
It has become a powerful tool to identify cell subpopulations
sharing similar transcriptome within a population, as well as to
provide information related to cell fate, development, lineage,
physiology, homeostasis and underlying molecular mechanisms
(2, 5, 6). The use of this recent technique has been described in
humans (7–9), mice (10) and other species (11, 12) in various
conditions and samples. In dogs, the use of this technique has
not yet been reported so far.
Bronchoscopy and combined analysis of the bronchoalveolar
lavage fluid (BALF) are largely used in the diagnosis of canine
lower airway diseases either acute or chronic (13, 14). In
dogs, bronchoalveolar lavage is a well-tolerated procedure and
few adverse effects are reported (13, 14). Common analyses
performed on BALF include determination of total (TCC)
and differential cell counts (DCC) (including macrophages,
neutrophils, lymphocytes, eosinophils, and mast cells count),
cytological examination of cytospin preparations, bacterial
cultures and detection of specific respiratory pathogens using
quantitative polymerase chain reactions (13, 14). Only few studies
have characterized the lymphocyte populations in the canine
BALF by flow cytometry (15–19) while the other cell types
have not been studied. In depth examination of BALF cellular
composition and subpopulations as well as the comparison of
these cell subpopulations in healthy and diseased conditions
could lead to the identification of new cell subsets involved in
disease and could help to better understand the pathophysiology
of lung diseases, the cell adaptations in disease context as well as
to find new or more specific therapeutic targets (6, 20).
In this study, we aimed to use the scRNA-seq technique in
healthy client-owned dogs to analyze BALF cell subpopulations.
Results will contribute to provide a base resource regarding cell
subpopulations composing the BALF of healthy dogs which could




For the scRNA-seq analysis, BALFs were obtained from healthy
dogs prospectively recruited at the veterinary clinic of the
University of Liège (CVU, Liège, Belgium) between December
2017 and June 2018. All dogs were privately owned, and samples
were obtained with owners’ consent. The study was validated
by the ethical committee of the University of Liège (approval
no. 1435).
The healthy status of the dogs was confirmed by history,
normal physical examination, blood work (plasma biochemistry
Abbreviations: ScRNA-seq, Single-cell RNA sequencing; BALF, Bronchoalveolar
lavage fluid; TCC, Total cell count; DCC, Differential cell count; UMI, Unique
Molecular Identifier; PCA, Principal component analysis; t-SNE, t-distributed
stochastic neighbor embedding; DEGs, Differentially expressed genes; GSEA, Gene
set enrichment analysis; GO, Gene ontology; DC, Dendritic cells; AMs, Alveolar
macrophages; Avg_logFC, Average log2 fold change.
and hematology), bronchoscopy and analysis of the BALF
(including a macroscopic evaluation, a TCC and a DCC). Dogs
from various breed and age were chosen to better represent the
diversity of the canine population.
Samples Collection
BALFs were obtained under anesthesia with butorphanol at 0.2
mg/kg (Butomidor R©, Richter Pharma AG, Wels, Austria) as
premedication and propofol (Diprivan R©, Asen Pharma Trading
Limited, Dublin, Irland) infusion on demand.
Dogs were not intubated for the procedure. A bronchoscope
(FUJINON© Pediatric Video-Bronchoscope EB-530S), cleaned
and disinfected using the washer-disinfector Serie 4 (Soluscope R©,
Aubagne, France), was inserted into the bronchi until the
extremity was wedged. Three to four mL/kg of a sterile NaCl
0.9% solution divided into 3 aliquots were instilled through the
endoscope channel into the lung (2 aliquots were obtained in
the right diaphragmatic lobe and one in the left diaphragmatic
lobe) and directly reabsorbed by gentle suction into the same
sterile recipient. About 1mL of BALF was kept for total and
differential cell count calculation performed using, respectively,
a hemocytometer and a cytospin preparation (centrifugation
at 221 g, for 4min at 20◦C, Thermo Shandon Cytospin©4),
by counting a total of 200 cells at high power field. The
rest of the BALF was then transferred within 15 to 20min




BALFs were filtered to remove mucus and total cell count
was assessed using a hemocytometer and Türk coloration
(Supplementary Table 1). BALFs were then centrifuged at 400 g
for 7min and the pellet resuspended in phosphate-buffered
saline solution (GibcoTM 1x DPBS, Cat.14190-169) to obtain
a cell concentration around 1,000 cells/µL. A second filtration
through a cell strainer (BD FalconTM, Biosciences, USA,
Cat.352350) was performed to remove any remaining cell debris
and large clumps and cells were again counted with Trypan
blue staining to assess cell viability considered as acceptable
above 70% (Supplementary Table 1). The volume of the cell
suspension was then adjusted to obtain a final cell concentration
between 500 and 1,000 cells/µL suspended in phosphate-buffered
saline solution containing 0.04% (w/v) bovine serum albumin
(Supplementary Table 1).
For each sample, ∼3,500 cells (Supplementary Table 1)
were loaded into the ChromiumTM Controller (10x Genomics,
Pleasanton, CA, USA) ∼30min after the first filtration and
were then partitioned into nanoliter scale vesicles containing
10x barcoded beads from ChromiumTM Single Cell 3′ Gel
Bead Kit v2 (10x Genomics, Pleasanton, CA, USA) according
to manufacturer’s instructions. The following steps take place
in the vesicles containing cell: [1] cell lysis, [2] capture of
polyadenylated mRNAs oligonucleotides containing cell specific
16 bp barcode and 10 bp Unique Molecular Identifier (UMI) and
[3] reverse transcription of mRNAs into cell specific barcoded
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cDNAs on a Veriti© 96-Well Thermal Cycler (ThermoFisher
Scientific, Merelbeke, Belgium).
Single-Cell Library Preparation and Sequencing
Emulsion breakage, cDNA amplification and libraries
construction were performed using ChromiumTM Single Cell 3′
Reagent kit v2 (10x Genomics, Pleasanton, CA, USA) according
to manufacturer’s instructions as already described (21).
Briefly, cDNAs obtained were amplified in a Veriti© 96-Well
Thermal Cycler. Amplified cDNA products were cleaned up,
quality controlled and quantified. Illumina’s P5, P7, and Read2
primers, as well as Sample Index were then added to generate
sequencing libraries. The barcoded sequencing libraries were also
quality controlled and quantified by quantitative PCR (KAPA
Biosystems Library Quantification Kit for Illumina platforms).
Sequencing libraries were loaded on an Illumina NextSeq500.
The sequencing depth was set at 50,000 reads per cell, taking
into account that ∼2,000 cells should be captured (55–60%
efficiency). Cell Ranger software (v1.2.0) (10x Genomics,
Pleasanton, CA, USA) was used to demultiplex Illumina BCL
files to FASTQ files (cellranger mkfastq), to perform alignment
to dog genome (CanFam3.1, GenBank assembly accession:
GCA_000002285.2), filtering, UMIs counting and to produce
gene-barcode matrices (cellranger count).
Data Analysis and Visualization
Analyses were performed using R package Seurat (version 3.1.2)
(22). Briefly, we have first selected cells with a minimum of 100
and a maximum of 2,500 unique mapped genes to exclude low-
quality cells or empty droplets and cell doublets or multiplets,
respectively. Only genes present in at least 3 different cells were
kept. Expression values were normalized to 10,000 transcripts
per cell and the “FindVariableFeatures” function was used to
identify the top 2,000 variable genes in each BALF sample.
“FindIntegrationAnchors” and “IntegrateData” functions were
used to combine the data of all BALF specimens, while
minimizing batch effects. Next, a linear transformation using the
“ScaleData” function was applied so that highly-expressed genes
do not dominate. A principal component analysis (PCA) was
performed on the scaled data using the command “RunPCA.”
The statistically principal components taken into account for
the next analysis were identified using the “PCElbowPlot” and
the “DimHeatmap” functions and were set to 1:30. A K-
nearest neighbor graph, based on the Euclidean distance in
PCA space and the Jaccard similarity index, was obtained using
the “FindNeighbors” function. Cells were then clustered with
the “FindClusters” command based on the Louvain algorithm.
Several cluster resolutions were tested, and the resolution of
0.3 was chosen, since higher resolutions created additional
subdivisions of non-well-defined clusters or clusters containing
singlets, which were considered not biologically relevant. The
data were visualized by a non-linear dimensional reduction, the
t-distributed stochastic neighbor embedding (t-SNE) plots, using
the “RunTSNE” function, with the number of dimensions to use
set to 30 (PC 1:30).
Cell types within each cluster were characterized based on the
identification of differentially expressed genes (DEGs) specific
for each cluster compared to all others. The “FindMarkers”
function was used to identify DEGs across clusters. Clusters with
the same identified cell type were also further characterized by
comparing DEGs between each other. The differential expression
was measured using non-parametric Wilcoxon rank sum tests
adjusted for multiple testing with Bonferroni correction. Only
DEGs with an adjusted P < 0.05 were retained. The genes
not well-annotated were further blasted on the Ensembl
genome browser (v99.31) (23) for dog species to increase the
annotation rate. Specific cell markers average expression and
percentage of cells expressing the indicated genes within clusters
were visualized with the “DotPlot” function. Alternatively, the
“FeaturePlot” function was used to show specific gene expression
within single cells.
The different common biological processes between clusters
with the same identified cell type were also assessed using the
gene set enrichment analysis (GSEA) using the online GSEA-
P software (24). GSEA was carried out by computing overlaps
between significantly enriched genes calculated between clusters
with the same identified cell type and gene ontology (GO)
biological process gene sets using hypergeometric tests with
Benjamini Hochberg correction for multiple testing (P-value
adjusted). Only the 10 first gene sets that best overlapped with
our gene set were retained.
Statistical Analysis
Single-cell mRNA sequencing data from the 4 samples were
pooled for all analysis. A P-value lower than 0.05 was considered
as significant. Details about statistical analysis for the scRNA-seq
data and the gene set enrichment analysis can be found in the
“Data analysis and visualization” section above.
RESULTS
Dogs Population Characteristics
Four healthy client-owned dogs were recruited for the
bronchoalveolar lavage procedure. The cohort was exclusively
composed by adult females including one 4-year-old French
bulldog, one 6-year-old Australian shepherd, one 9-year-
old West Highland white terrier and one 11-year-old
Yorkshire terrier.
BALF Cells Analysis
Information about TCC and DCC for each BALF can be found in
the Table 1.
Single-Cell RNA Sequencing
The transcriptomic profile from a total of 5,710 cells was obtained
from each of the four BALF specimens using 10x Genomics based
scRNA-seq analysis. Cells had a mean read depth of ∼54,000
reads per cell. Summary of sequencing and mapping quality
control metrics for each BALF sample is presented in Table 2.
The distribution of transcripts and genes counts can be found in
the Supplementary Figures 1A,B.
Cells from all dogs were compiled after identification
of anchors using Seurat. The clustering in Seurat allowed
the detection of 14 well-defined clusters (Figure 1A). The
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contribution of each individual sample in the compiled t-SNE
figure is displayed in Figures 1B,C. Cells coming from each of
the four BALF specimens were present in all identified clusters
except for the cluster 11 which did not contain cells from BALF 1
(Figure 1C). The average expression of all transcripts detected by
clusters is provide in the Supplementary Table 2.
The cell identity of each cluster was determined based
on the DEGs in each cluster compared to all others. All
DEGs are reported in the Supplementary Table 3. In each
cluster, a selection of the most overexpressed transcripts able to
differentiate cell types according to the literature is displayed
in Table 3. Cells of clusters 0, 3, 5, and 8 expressing MARCO
and/or MSR1 and/or HLA-DRB1 and/or CD163 and/or CD86
and/or MRC1 and/or CD68 and/or CD63 were identified as
macrophages/monocytes (25–32). Cells of cluster 1 and 2
expressing CD3 markers were identified as T lymphocytes (28,
33). Cells of clusters 4 and 12 expressing TFF1, TFF3 and KRT19
or just KRT19, respectively, were identified as epithelial cells (34,
35). Cells of clusters 7 and 13 expressing CD83 and either CD1E
or CCR7, respectively, were identified as dendritic cells (DC).
Finally, cells of cluster 6 expressing CD62L and ITGAM were
identified as neutrophils (36), cells of cluster 9 expressing PCLAF,
TOP2A andKi-67 as cycling cells (8), cells of cluster 10 expressing
BCR, FCRLA and CD19 as B lymphocytes (37–39) and finally,
cells of cluster 11 expressing MS4A2, FCER1G, KIT and CD63
TABLE 1 | Total and differential cell count in each bronchoalveolar lavage fluid.
BALF 1 BALF 2 BALF 3 BALF 4
TCC, cells/µL 440 880 570 180
DCC, % Macrophages 70 80 91 71
Neutrophils 10 12 3 12
Lymphocytes 18 5 3 10
Eosinophils 1 3 1 2
Mast cells 0 0 0 0
Epithelial cells 1 0 2 5
BALF 1, female Yorkshire terrier of 11-year-old; BALF 2, female French bulldog of 4-year-
old; BALF 3, female West Highland white terrier of 9-year-old; BALF 4, female Australian
shepherd of 6-year-old; TCC, total cell count; DCC, differential cell count.
as mast cells (40) (Table 3 and Figure 2). The proportions of the
different identified cell types in the global dataset corresponded
to 50.4% of macrophages/monocytes, 28.9% of lymphocytes B
and T, 9.5% of epithelial cells, 4.1% of neutrophils, 3.9% of DC
2.2% of cycling cells and 1.0% of mast cells. Of note, we were
not able to identify eosinophils, cells known to be present in
BALF (13).
DEGs and biological processes were further compared
between clusters sharing the same cell identity, namely
macrophages/monocytes, T lymphocytes, epithelial cells and DC,
to better characterize each cluster.
The graph-based clustering of merged single-cells
identified four transcriptionally distinct clusters of
macrophages/monocytes. In this study, MARCO, a class A
scavenger receptor involved in host defense and demonstrated
to be highly expressed in embryonic-derived or alveolar
macrophages (AMs) and not expressed in monocyte-derived
macrophages was used to identify AMs (25, 27). MARCO
was overexpressed in the clusters 0, 3, and 5 compared to all
remaining clusters (Figure 2 and Supplementary Table 3).
The first cluster of AMs (cluster 0) represented the majority
of the macrophages/monocytes cells and showed a unique
transcriptional signature including upregulation of transcripts
coding for cell surface markers such as MHC-II molecules
(e.g., DLA-DQA1, DLA-DRA, DLA-DMA), CD63, the Fc
fragment of IgG receptor IIIa (FCGR3A, encoding CD16),
the selectin L (SELL, encoding CD62L), the CD36 molecule,
the CD68 molecule and the lysosomal associated membrane
protein 2 (LAMP2) (Supplementary Table 4). Other most
upregulated transcripts (average log2 fold change (avg_logFC)
> 0.5, P < 0.05) included the apolipoprotein E (APOE)
known as an anti-inflammatory, anti-proliferative and immune-
modulatory protein (41) and transcripts involved in the immune
response such as for example the bactericidal permeability
increasing protein (BPI) and the complement C1q A chain
(C1QA) (Figure 3 and Supplementary Table 4). The principal
biological functions exerted by cells in cluster 0 are reported
in Table 4.
Compared with macrophages composing clusters 0, 5 and 8,
the AMs composing cluster 3 overexpressed (avg_logFC > 0.5,
P < 0.05) transcripts encoding cell surface markers such
TABLE 2 | Metrics about mapping and characteristics of the detected cells of each BALF sample.
BALF 1 BALF 2 BALF 3 BALF 4
Number of cells passing quality control 1,309 1,072 1,298 2,031
Reads mapped confidently to genome, % 68.1 68.6 59.8 72.4
Reads mapped confidently to transcriptome, % 26.5 30.4 23.9 30.7
Median genes/cell 485 (229–2,480) 780 (350–1,313) 834 (376–1,046) 407 (215.25–953)
Median UMIs/cell 1020 (321–3,351) 1942 (720–4,003) 1888.5 (678–2,671) 837 (430–2,669)
Total genes detected 11,343 11,133 10.839 11,543
Data were generated after passing quality control including the exclusion of cells with <100 and >2,500 genes. Reads mapped confidently to genome are the number of reads that
mapped only to the genome. Reads mapped confidently to transcriptome are the fraction of the reads mapped to a unique gene in the transcriptome and are considered for UMI
counting. Median genes per cell correspond to the median number of genes with at least one UMI count. Total genes detected is the detected number of genes with at least one UMI
count in any cell. BALF 1, female Yorkshire terrier of 11-year-old; BALF 2, female French bulldog of 4-year-old; BALF 3, female West Highland white terrier of 9-year-old; BALF 4, female
Australian shepherd of 6-year-old; UMI, unique molecular identifier.
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FIGURE 1 | Compiled t-SNE plot of the cell clusters. (A) t-SNE plot of all cells (n = 5,710) representing the cell clusters analyzed by scRNA-seq. Each color
corresponds to one cluster assigned via the graph-based clustering method with a resolution of 0.3. (B) Batch alignment across bronchoalveolar lavage fluid (BALF)
specimens, each color representing the cells coming from one sample. (C) Bar plot showing the relative proportion of the cell from each BALF sample into each
cluster. BALF 1, female Yorkshire terrier of 11-year-old; BALF 2, female French bulldog of 4-year-old; BALF 3, female West Highland white terrier of 9-year-old; BALF
4, female Australian shepherd of 6-year-old.
as the macrophage mannose receptor (MRC1, encoding
CD206), the integrin subunit alpha 5 (ITGA5), the scavenger
receptor CD163, the CD80 molecule and the CD83 molecule
(Supplementary Table 4). The cells in cluster 3 also largely
overexpressed transcripts (avg_logFC > 0.5, P < 0.05)
encoding cytokines, including the interleukin 18 (IL18), the
C-C motif chemokine ligand 4 and 5 (CCL4 and CCL5) and the
interleukin 10 (IL10) (Figure 3 and Supplementary Table 4).
Such combination of pro-inflammatory and immunoregulatory
cytokines is consistent with the enriched functional properties
of the cells in cluster 3 which include regulation of the immune
response and cell activation (Table 4).
AMs in cluster 5, in comparison with cells from clusters
0, 3 and 8 also overexpressed transcripts encoding cell
surface markers (avg_logFC > 0.5, P < 0.05), including
the CD9 molecule, the CD5 molecule like (CD5L),
CD68, the carcinoembryonic antigen related cell adhesion
molecule 5 (CEACAM5) and the CD300C molecule
(Supplementary Table 4). The principal functions of AMs
composing cluster 5 were quite similar to those associated
with AMs in cluster 0. However, those cells seemed to be
more involved in cellular homeostasis (Table 4), mostly
metal ion homeostasis. Indeed, the most enriched transcripts
in the cluster 5 were the metallothionein 1X (MT1X) and
the metallothionein 2A (MT2A) which encode anti-oxidant
proteins that are important in the homeostasis of metal in the
cell, and in the detoxification of heavy metals (Figure 3 and
Supplementary Table 4) (42, 43).
The cells in cluster 8 compared with other clusters did
not overexpress the transcript encoding MARCO and were
not considered as AMs. Overexpressed transcripts coding for
surface markers in cluster 8 compared with clusters 0, 3,
and 5 included MHC-II (DLA-DQA1) and MHC-I (DLA-88)
molecules, the tumor necrosis factor superfamily member 13b
(TNFSF13B), the colony stimulating factor 2 receptor subunit
beta (CSF2RB), the integrin subunit alpha X (ITGAX) and the
CD1e molecule (Supplementary Table 4). The cells in cluster 8
were characterized by the overexpression (avg_logFC > 0.5, P <
0.05) of transcripts encoding cytokines including the interleukin
1 receptor antagonist (IL1RN), the C-C motif chemokine ligand
23 (CCL23), the C-C motif chemokine ligand 2 (CCL2) and
the C-X-C motif chemokine ligand 10 (CXCL10) (Figure 3 and































TABLE 3 | Selection of significant DEGs able to differentiate cell type in each cluster based on literature.


































MARCO 1.03 83 −1 48 −0.99 60 0.28 25 −0.97 0 0.35 94 −0.97 51 −0.95 38 −0.91 20 −0.96 0 −0.94 24 −0.96 27
MSR1 0.99 88 −1.23 46 −1.2 59 0.63 35 −1.2 16 −1.24 17 −1.22 20 −1.22 27
HLA–DRB1 0.85 100 −1.18 84 −1.5 87 −3.27 26 −2.47 76 1.33 100 0.63 100 −3.25 19 −2.23 22 −2.1 73
CD163 0.7 87 −1.31 24 −1.28 20 1.17 45 −1.25 14 −1.13 39 −1.22 16
CD86 0.66 86 −1.27 52 −1.16 59 0.86 57 −1.31 0 −1.03 52 0.76 91 0.4 79 −0.80 50 −1.25 76 −1.22 16
MRC1 0.6 91 −1.68 44 −1.69 54 −1.71 12 −0.52 92 −1.68 65 0.43 83 −1.51 43 −1.67 26 −1.6 20
CD68 0.97 86 −1.19 36 −1.16 54 −1.18 0 0.84 96 −1.13 27 −0.79 3 −1.01 18
CD63 0.85 99 −0.98 64 −1.17 68 −0.26 49 −1 30 0.39 100 −0.5 43 0.32 97 −1.12 72 1.76 97 −0.51 33
DC markers CD1E 0.87 79 0.26 55
CD83 0.26 71 −1.06 7 −1.08 16 −0.78 17 0.57 83 −0.57 27 −1.04 8 2.63 100
CCR7 3.24 93
T cells markers CD3E −1.75 58 1.37 77 1.54 87 −1.56 4 −1.57 55 −1.43 25 0.26 73
CD3D −1.6 56 1.41 72 1.39 83 −1.32 2 −1.39 55 −1.27 39 −1.39 22
Epithe-lial cells
markers
TFF3 −3.92 61 −4.15 67 −3.29 79 6.18 99 −4.17 93 −3.5 54 −3.24 77 −4.46 67
TFF1 −3.31 58 −3.42 64 −2.31 78 5.4 95 −3.3 93 −2.66 77 −3.82 81 −3.39 28


















B cells markers ENSCAFG0
0000030258
(BCR)





MS4A2 −0.6 33 −0.51 39 −0.45 56 −0.39 75 −0.49 2 0.78 44 −0.33 11 3.71 78
KIT −0.30 1 0.42 81 3.13 100
FCER1G 0.58 98 −1.89 21 −2.17 49 −2.19 4 1.46 83 0.5 94 −2.08 58 2.21 92 −2.09 26
The avg logFC was calculated by comparing each cluster to all other clusters, overexpressed transcripts are displayed in bold. Only significant data were reported in the table (P < 0.05). DEGs, differentially expressed genes; Avg logFC,
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FIGURE 2 | Identification of cell identity corresponding to the clusters. t-SNE plot showing the cells identity based on the expression of differentially expressed genes
representative of each cells type including genes coding for the macrophage receptor with collagenous structure (MARCO), the macrophage mannose receptor
(MRC1, encoding CD206), the T-cell surface glycoprotein CD3 epsilon chain (CD3E), the cytokeratin 19 (KRT19), the selectin (SELL, encoding CD62L), the integrin
alpha M (ITGAM), the T-cell surface glycoprotein CD1e (CD1E), the CD83 molecule, the Fc receptor like A (FCRLA), the CD19 molecule, the DNA topoisomerase II
alpha (TOP2A), the proliferating cell nuclear antigen clamp associated factor (ENSCAFG00000030087, encoding PCLAF ), the membrane spanning 4-domains A2
(MS4A2) and the mast/stem cell growth factor receptor (KIT ). DC, dendritic cell.
Supplementary Table 4). The high level of cytokine transcripts
in cluster 8 is consistent with the enrichment for processes related
to the inflammatory response, the defense response and the
response to cytokines (Table 4).
By looking at the DEGs and the GSEA between cluster 1 and
cluster 2 corresponding each to T cells (Supplementary Table 5
and Table 5), we were able to characterize cells in cluster 1
as cytotoxic or CD8+ T cells. Indeed, the transcripts encoding
granzyme B, K, and A (GZMB, GZMK, and GZMA, respectively)
were overexpressed with an avg_logFC > 1 in cluster 1
compared to cluster 2 (Supplementary Table 5). Those genes are
expressed by cytotoxic T lymphocytes and natural killer cells
Frontiers in Immunology | www.frontiersin.org 7 July 2020 | Volume 11 | Article 1707
Fastrès et al. scRNA-seq in BALF of Healthy Dogs
FIGURE 3 | Single-cell mRNA-sequencing based identification of 4 distinct subpopulations of macrophages/monocytes in the bronchoalveolar lavage fluid of dogs.
Dot plots showing the average expression of the indicated genes as well as the percentage of cells expressing the genes within each cluster of
macrophages/monocytes. An example of transcripts significantly (P-value adjusted < 0.05) differentially upregulated (average log2 fold change > 0.5) between the
clusters 0, 3, 5, and 8 are depicted.
(44, 45). Other transcripts with an avg_logFC > 1 in cluster 1
compared to cluster 2 included the killer cell lectin like receptor
D1 and K1 (KLRD1 and KLRK1, respectively) also expressed
primarily in natural killer cells and CD8+ T cells (45, 46).
Finally, the CD8b molecule was also overexpressed in cluster 1
(Supplementary Table 5).
When comparing cluster 2 to cluster 1, enriched biological
processes were more in favor of CD4+ T cells, as reported in
Table 5. Although classical surface marker of this cell type was
not expressed by the cells in our dataset (e.g., CD4), the cells in
cluster 2 overexpressed transcripts encoding for the interleukin 7
receptor (IL7R) and the CD40 ligand (Cd40L) commonly found
in CD4+ T cells (47, 48). Principal overexpressed transcripts
in cluster 2 included ICOS (inducible T cell costimulatory) an
important costimulatory factor expressed in activated T cells
(49–51), PLAC8 (placenta associated 8), GATA3 (GATA binding
protein 3) and ANXA1 (annexin A1) (Supplementary Table 5).
Those transcripts are associated with the activation of CD4+ T
cells, T cell differentiation in CD4+ T cells and immune response
modulation (52–55), which is coherent with the functions of
CD4+ T cells as reported in Table 5.
Diverse epithelial populations were captured and
corresponded to clusters 4 and 12. Cluster 12 was identified as
composed by ciliated epithelial cells as it included functions such
as cilium movement, microtubule-based process and movement,
cytoskeleton and cell projection organization (Table 6). Indeed,
the most enriched transcript in cluster 12 compared to cluster
4 included notably the transcripts encoding SNTN (sentan,
cilia apical structure protein), DPCD [deleted in primary
ciliary dyskinesia homolog (mouse)], ROPN1L (rhophilin
associated tail protein 1 like), SPA17 (sperm autoantigenic
protein 17) and WDR78 (WD repeat domain 78) for example
(Supplementary Table 6).
Cells in cluster 7 and 13 were identified as DC. Compared with
cells in cluster 13, cells in cluster 7 overexpressed (avg_logFC> 1)
transcripts coding for MHC-II and MHC-I molecules (i.e., HLA-
DRB1, HLA-DQA1, DLA-DMA, DLA-DQA1, DLA-DRA, DLA-
DOA, DLA-88, and DLA-79) (Supplementary Table 7) and their
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TABLE 4 | Top 10 gene set overlap between significantly upregulated genes in cluster 0, 3, 5 and 8 compared to each other and the gene ontology (GO) biological
process gene set.
Gene set name Genes in gene set (K) Positive DEGs included Genes in overlap (k) k/K FDR q-value
Cluster 0 vs. 3,
5 and 8
Myeloid leukocyte activation 650 88 28 0.0431 1.23E-24
Leukocyte mediated immunity 867 88 30 0.0346 3.06E-24
Cell activation involved in immune response 705 88 28 0.0397 3.36E-24
Myeloid leukocyte mediated immunity 550 88 26 0.0473 3.36E-24
Exocytosis 899 88 29 0.0323 8.10E-23
Immune effector process 1,253 88 32 0.0255 1.42E-22
Cell activation 1,424 88 32 0.0225 6.03E-21
Secretion 1,638 88 31 0.0189 4.86E-18
Defense response 1,709 88 26 0.0152 2.40E-12
Innate immune response 984 88 21 0.0213 2.50E-12
Cluster 3 vs. 0,
5 and 8
Response to cytokine 1,192 251 45 0.0378 4.29E-18
Regulation of immune system process 1,631 251 47 0.0288 1.22E-14
Positive regulation of protein metabolic
process
1,633 251 46 0.0282 3.81E-14
Cell activation 1,424 251 43 0.0302 3.81E-14
Cell motility 1,719 251 46 0.0268 1.95E-13
Response to oxygen containing compound 1,616 251 44 0.0272 4.45E-13
Locomotion 1,943 251 48 0.0247 6.01E-13
Defense response 1,709 251 44 0.0257 2.46E-12
Regulation of cell activation 608 251 27 0.0444 3.06E-12
Interspecies interaction between organisms 927 251 32 0.0345 7.69E-12
Cluster 5 vs. 0,
3 and 8
Myeloid leukocyte activation 650 62 16 0.0246 1.70E-11
Myeloid leukocyte mediated immunity 550 62 15 0.0273 1.70E-11
Exocytosis 899 62 17 0.0189 5.14E-11
Cell activation involved in immune response 705 62 15 0.0213 2.91E-10
Leukocyte mediated immunity 867 62 16 0.0185 2.91E-10
Secretion 1638 62 20 0.0122 2.91E-10
Cell activation 1,424 62 18 0.0126 2.95E-09
Immune effector process 1253 62 17 0.0136 3.90E-09
Cellular homeostasis 971 62 14 0.0144 1.69E-07
Homeostatic process 1,913 62 18 0.0094 2.57E-07
Cluster 8 vs. 0,
3 and 5
Defense response 1,709 59 20 0.0117 1.22E-09
Cell motility 1,719 59 19 0.0111 7.91E-09
Cytokine mediated signaling pathway 787 59 14 0.0178 1.49E-08
Locomotion 1,943 59 19 0.0098 3.31E-08
Inflammatory response 722 59 13 0.018 4.87E-08
Leukocyte migration 488 59 11 0.0225 1.29E-07
Response to cytokine 1,192 59 15 0.0126 1.29E-07
Response to bacterium 681 59 12 0.0176 2.45E-07
Response to biotic stimulus 1,023 59 13 0.0127 1.88E-06
Regulation of immune system process 1,631 59 15 0.0092 6.45E-06
Gene set enrichment analysis carried on by computing overlaps between significantly upregulated genes (P < 0.05, avg_logFC > 0.25) and the gene ontology biological process gene
set. “Genes in Gene Set” refers to the number of genes in the gene set, “Positive DEGs included” corresponds to the number of positive differentially expressed genes in the cluster of
interest compared to the others and “Genes in Overlap” to the number of genes upregulated in the cluster and involved in the biological process. Avg_logFC, average log2 fold change.
major functions concerned the activation of immune cells and the
defense response.
Overexpressed surface marker transcripts identified in cells of
cluster 13 compared to cluster 7 (avg_logFC> 1) included the C-
C motif chemokine receptor 7 and the C-X-C motif chemokine
receptor 4 (CCR7 and CXCR4, respectively), the CD83 molecule
and the programmed cell death 1 ligand 2 (PDCD1LG2)
(Supplementary Table 7). The major functions of cells in cluster
13 concerned mostly the regulation of the activation of immune
cells (Table 7). Because of their overexpression of CD83 and
CCR7, we considered that DC of cluster 13 correspond to mature
DC (56, 57).
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TABLE 5 | Top 10 gene set overlap between significantly upregulated genes in cluster 1 and 2 compared to each other and the gene ontology (GO) biological process
gene set.
Gene set name Genes in gene set (K) Positive DEGs included Genes in overlap (k) k/K FDR q-value
Cluster 1 vs. 2 Regulation of immune system process 1,631 24 13 0.008 1.85E-08
Innate immune response 984 24 11 0.0112 2.20E-08
Regulation of immune response 1,094 24 11 0.0101 4.58E-08
Natural killer cell mediated immunity 65 24 5 0.0769 9.46E-07
Defense response 1,709 24 11 0.0064 3.10E-06
Regulation of natural killer cell chemotaxis 9 24 3 0.3333 2.26E-05
Natural killer cell chemotaxis 11 24 3 0.2727 3.81E-05
Lymphocyte mediated immunity 344 24 6 0.0174 5.41E-05
Lymphocyte chemotaxis 62 24 4 0.0645 5.41E-05
Cell activation 1,424 24 9 0.0063 8.11E-05
Cluster 2 vs. 1 Regulation of lymphocyte activation 478 37 12 0.0251 1.38E-10
Regulation of cell activation 608 37 12 0.0197 8.27E-10
Regulation of T cell activation 313 37 10 0.0319 8.27E-10
T cell activation 459 37 11 0.024 8.27E-10
Regulation of cell death 1,723 37 16 0.0093 2.23E-09
Lymphocyte activation 721 37 12 0.0166 2.88E-09
Apoptotic process 1,980 37 16 0.0081 1.30E-08
Biological adhesion 1,417 37 14 0.0099 2.16E-08
Cell activation 1,424 37 14 0.0098 2.16E-08
Leukocyte cell-cell adhesion 336 37 9 0.0268 2.16E-08
Gene set enrichment analysis carried on by computing overlaps between significantly upregulated genes (P < 0.05, avg_logFC > 0.25) and the gene ontology biological process gene
set. “Genes in Gene Set” refers to the number of genes in the gene set, “Positive DEGs included” corresponds to the number of positive differentially expressed genes in the cluster of
interest compared to the other and “Genes in Overlap” to the number of genes upregulated in the cluster and involved in the biological process. Avg_logFC, average log2 fold change.
TABLE 6 | Top 10 gene set overlap between significantly upregulated genes in cluster 4 and 12 compared to each other and the gene ontology (GO) biological process
gene set.
Gene set name Genes in gene set (K) Positive DEGs included Genes in overlap (k) k/K FDR q-value
Cluster 12 vs. 4 Microtubule based process 734 93 14 0.0191 7.90E-06
Epithelial cilium movement 23 93 5 0.2174 7.90E-06
Cilium movement 65 93 6 0.0923 2.00E-05
Cytoskeleton organization 1298 93 17 0.0131 2.00E-05
Microtubule based movement 277 93 9 0.0325 3.13E-05
Regulation response to stress 1,497 93 17 0.0114 8.91E-05
Cell projection organization 1,512 93 16 0.0106 5.00E-04
Reproduction 1,459 93 15 0.0103 1.49E-03
Actin filament bundle organization 155 93 6 0.0387 1.59E-03
Central nervous system development 980 93 12 0.0122 2.54E-03
Gene set enrichment analysis carried on by computing overlaps between significantly upregulated genes (P < 0.05, avg_logFC > 0.25) and the gene ontology biological process gene
set. No overlap was found between the gene set and upregulated genes of the cluster 4 compared to the cluster 12. “Genes in Gene Set” refers to the number of genes in the gene set,
“Positive DEGs included” corresponds to the number of positive differentially expressed genes in the cluster of interest compared to the other and “Genes in Overlap” to the number of
genes upregulated in the cluster and involved in the biological process. Avg_logFC, average log2 fold change.
DISCUSSION
In this paper, we report for the first-time a comprehensive single-
cell expression profiling of the canine BALF cells in healthy
condition. We were able to cluster cells in 14 distinct subsets
identified as macrophages/monocytes, CD8+ T cells, CD4+ T
cells, epithelial cells, ciliated epithelial cells, mature DC and DC,
neutrophils, B cells, mast cells and cycling cells.
Until recently, cells of the dog BALF were only characterized
by microscopic evaluation or, in rare cases, by flow cytometry.
The cell populations identified by these techniques included
macrophages, CD4+ and CD8+ lymphocytes, neutrophils,
eosinophils, mast cells and epithelial cells (13–19, 58). With
the use of the scRNA-seq, we highlighted the presence of 14
subpopulations of cells using an unbiased technique. We were
able to characterized the cells composing those subpopulations
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TABLE 7 | Top 10 gene set overlap between significantly upregulated genes in clusters 7 and 13 compared to each other and the gene ontology (GO) biological process
gene set.
Gene set name Genes in gene set (K) Positive DEGs included Genes in overlap (k) k/K FDR q-value
Cluster 7 vs. 13 Cell activation 1424 218 59 0.0414 3.15E-31
Myeloid leukocyte activation 650 218 43 0.0662 4.95E-30
Myeloid leukocyte mediated immunity 550 218 38 0.0691 5.41E-27
Cell activation involved in immune response 705 218 41 0.0582 1.26E-26
Immune effector process 1,253 218 51 0.0407 1.26E-26
Exocytosis 899 218 44 0.0489 8.25E-26
Leukocyte mediated immunity 867 218 43 0.0496 1.90E-25
Secretion 1,638 218 54 0.033 3.62E-24
Defense response 1,709 218 51 0.0298 1.02E-20
Regulation of immune system process 1,631 218 46 0.0282 1.96E-17
Cluster 13 vs. 7 Cell activation 1,424 85 23 0.0162 2.66E-10
Regulation of lymphocyte activation 478 85 14 0.0293 6.34E-09
Lymphocyte activation 721 85 16 0.0222 6.34E-09
Regulation of immune system process 1,631 85 22 0.0135 6.34E-09
Regulation of cell activation 608 85 15 0.0247 6.34E-09
Regulation of T cell activation 313 85 12 0.0383 6.34E-09
Response to biotic stimulus 1,023 85 18 0.0176 8.72E-09
T cell activation 459 85 13 0.0283 2.55E-08
Cytokine production 759 85 15 0.0198 9.27E-08
Response to cytokine 1,192 85 17 0.0143 6.25E-07
Gene set enrichment analysis carried on by computing overlaps between significantly upregulated genes (P < 0.05, avg_logFC > 0.25) and the gene ontology biological process gene
set. “Genes in Gene Set” refers to the number of genes in the gene set, “Positive DEGs included” corresponds to the number of positive differentially expressed genes in the cluster of
interest compared to the other and “Genes in Overlap” to the number of genes upregulated in the cluster and involved in the biological process. Avg_logFC, average log2 fold change.
in depth and to deduce their main functions based on their
transcriptome. In addition to offer a way to overcome the lack
of qualitative reagents designed for flow cytometry in dogs, the
scRNA-seq allows a better characterization of cell heterogeneity
without prior knowledge by highlighting, in better agreement
with pulmonary physiology, all cell types and cell functions.
Indeed, the scRNA-seq provides comprehensive profiles of cells
without limitations due to pre-selected cells by probing a few
selected markers (5, 6, 20, 59, 60).
Four subpopulations of macrophages/monocytes were found.
Among them, 3 subpopulations corresponded to AMs based
on their expression of MARCO (25, 27). AMs are the most
abundant cells found in the airways in homeostatic conditions.
They are self-maintaining with minimal contributions from
circulating monocytes in healthy conditions (25, 61, 62).
The first subpopulation of AMs, representing the major cell
subpopulation, exerted functions involved in immune defense
and response. The second was enriched in a combination
of pro and anti-inflammatory cytokines transcripts and
exerted functions involved in the regulation of the immune
response. Finally, the third population had similar functions
as the first with more implications in the homeostasis and
the detoxification of metal ions. The last subpopulation was
not considered as AMs and could correspond to monocytes-
derived macrophages or monocytes. Indeed, the cluster
was the smallest and expressed macrophages markers but
notMARCO.
We found a large population of non-ciliated cells and a small
population of ciliated cells corresponding to tracheobronchial
epithelial cells.
T lymphocytes were subdivided into 2 subpopulations
identified as CD8+ and CD4+ with a majority of CD8+ T cells
which was already reported in healthy dogs particularly in aged
animals (16, 17). Indeed, cells in cluster 1 expressed the CD8b
molecule. However, cells in cluster 2 did not express neither
CD8 nor CD4 while they overexpressed markers associated with
classical CD4+ T cells such as GATA3, IL7R and the CD40 ligand
(47, 48, 53, 54). The absence of CD4 mRNA expression could
be due to weakness or absence of transcription of this protein
(60). Indeed, in dogs, a population of CD8−CD4− T cell has been
described representing ∼15% of the TCRαβ+ T cells in the lung,
also expressing GATA3 (63). Cells from cluster 2 cells possibly
belong to this population.
B cells were identified using BCR, FCRLA and CD19 markers
(37–39). CD19 has only recently been described as B cell marker
in dogs (39) which highlights the benefice of the scRNA-seq
for the identification of new surface markers to better isolate
different cell types (5, 6). Common B cell surface markers used
and described in dogs include CD21 and CD79A (64). In this
study, CD21 mRNA was not detected which could be due to
absent or weak transcription of this protein (60). CD79A was
expressed in B cells but its expression was low and it was not
significantly differentially expressed in the cluster 10 compared
to others.
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The identified granulocytic populations included neutrophils
and mast cells. Basophils and mast cells shared common markers
including MS4A2, KIT and FCER1G used in our study (40).
However, overexpressed DEGs in cluster 11 cells also included
chymase (encoding CMA1) and tryptase enzymes (encoding
PPSAB1 and TSP2) which are almost entirely mast cell-specific
(40, 65, 66). The cells in cluster 11 also expressed CD63 which
is considered as one of the most useful markers of mast cell
and basophil activation (40, 66). We did not identify mast cells
in BALF 1 which is probably due to the small proportion of
that cell type into BALF samples (13). Indeed, it represents only
1.0% of the total cells recovered in this analysis and it is possible
that rare cell populations may not be properly captured with
the 10X Genomics Chromium system (60). We were not able to
identify a cluster of eosinophils, which are normally present in
dog BALF specimens (13). Although the number of eosinophils
found in the BALF of healthy dogs is rather low (13) and may
not be properly captured, their total absence from our dataset is
most likely related to their high content of RNase (67) inducing
the rapid degradation of mRNA, thus preventing their detection
by scRNA-seq.
Finally, two subpopulations of DC were also found one being
identified as mature DC because of its higher expression of CD83
and CCR7 (56, 57).
The use of the scRNA-seq in dogs has some limitations. The
principal impediment to apply scRNA-seq to canine samples is
the necessity to map sequenced RNAs on a sufficiently well-
annotated database to be able to identify genes. The percentage
of reads mapped confidently to the transcriptome in this study
was considered as low (∼28%) as it is expected to be >
30%1. This can be due to a poor annotation of the reference
transcriptome (overlapping genes for example), but could also
be related to a poor library, sequencing or reads quality 1.
However, despite this suboptimal mapping, we were able to
identify cell clusters and deduce clusters principal functions
based on the cell transcriptome obtained. Another limitation
is the lack of information for the identification of specific cell
markers in dogs. For example, in the 4 clusters identified as
macrophages/monocytes, AMs were recognized only by their
expression of MARCO. In the literature in human and mouse,
the expression of SIGLECF, MERTK, CD14, CCR2, and Ly-6c
are commonly used to distinguish AMs from monocytes and
monocyte-derived macrophages (8, 21, 26, 27, 68, 69). However,
those markers were not detected in our dataset. The use of
the 10X Genomics Chromium system although being unbiased,
time saving and allowing high throughput and high-resolution
transcriptomic analysis, also implies that rare cell populations
may not be properly captured and that sensitivity is reduced
decreasing the detection of weakly expressed genes (60). It is
possible that common markers used to identify different cell
types are only weakly expressed making cell populations difficult
to identify. Finally, a limited number of dogs was used in the
study. Indeed, as the use of the scRNA-seq is quite expensive,
only 4 BALF samples were analyzed with a relatively low
1https://support.10xgenomics.com/single-cell-gene-expression/software/
pipelines/latest/troubleshooting#alerts (accessed March 16, 2020).
median number of cells and reads per sample (∼1,300 cells
and ∼54,000 reads, respectively). The 4 selected dogs included
young to old adult dogs from 4 breeds differing in size and body
conformation, in order to be, as much as possible, representative
of the whole healthy canine population, even if no males were
sampled. However, we don’t expect the sex to alter BALF cells
transcriptome. While it has been shown that the age could
alter the cell proportions in the BALF from healthy dogs (70),
we are not aware of studies assessing its effect on BALF cells
transcriptome either. To our knowledge, no study has specifically
investigated the effect of the sex and the breed on canine BALF
cells proportions and transcriptome. Besides, in the present
study, cells coming from each of the four BALF specimens were
present in nearly all identified clusters indicating that similar cell
populations were present in all dogs.
CONCLUSION
ScRNA-seq is a new technique which enables unbiased, high
throughput and high-resolution transcriptomic analysis and
which can be used to identify cell populations in the BALF
of healthy dogs. In this study, we provide a comprehensive
single-cell transcriptome tool. It represents a highly informative
dataset for the identification and subsequent interpretation of cell
populations and molecular signatures alterations in lung diseases
in dogs.
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